Stephen G Davies Insider Profile
4 Followers
Stephen G Davies, former Director at Summit Therapeutics, holds 8.16M shares in Summit Therapeutics (Ticker: GB:SUMM). Most recently, Stephen G Davies Bought 500,000 shares of Summit Therapeutics on Apr 05, 2012 for an estimated value of 15.00K .
Stephen G Davies's Trading History
| SUMMSummit Therapeutics | Apr 05, 2012 | ― | Informative Buy | 15.00K | £3.06M | |||||||||||||||||||||||||||||||||||||||||||
GB:SUMM
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Stephen G Davies insider profile FAQ
What is the percentage of profitable transactions made by Stephen G Davies?
The percentage of profitable transactions made by Stephen G Davies is 20%.
What is the average return per transaction made by Stephen G Davies?
The average return per transaction made by Stephen G Davies is -30.80%.
What stocks does Stephen G Davies hold?
Stephen G Davies holds: GB:SUMM stocks.
What was Stephen G Davies’s latest transaction?
Stephen G Davies’s latest transaction was an Informative Buy of 15.00K .
What is Stephen G Davies's role in Summit Therapeutics?
Stephen G Davies's role in Summit Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
